These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 33152826)

  • 1. [The malignant transformation after denosumab-treated giant cell tumor of bone and the H3F3A mutation syndrome].
    Gong LH; Liu WF; Shan HC; Sun XQ; Zhang M; Ding Y; Niu XH
    Zhonghua Bing Li Xue Za Zhi; 2020 Nov; 49(11):1177-1179. PubMed ID: 33152826
    [No Abstract]   [Full Text] [Related]  

  • 2. Giant cell tumours of bone treated with denosumab: histological, immunohistochemical and H3F3A mutation analyses.
    Kato I; Furuya M; Matsuo K; Kawabata Y; Tanaka R; Ohashi K
    Histopathology; 2018 May; 72(6):914-922. PubMed ID: 29206281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histone H3.3 mutation in giant cell tumor of bone: an update in pathology.
    Yamamoto H; Ishihara S; Toda Y; Oda Y
    Med Mol Morphol; 2020 Mar; 53(1):1-6. PubMed ID: 31748824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Denosumab treated giant cell tumour of bone: a morphological, immunohistochemical and molecular analysis of a series.
    Girolami I; Mancini I; Simoni A; Baldi GG; Simi L; Campanacci D; Beltrami G; Scoccianti G; D'Arienzo A; Capanna R; Franchi A
    J Clin Pathol; 2016 Mar; 69(3):240-7. PubMed ID: 26338802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic utility of histone H3.3 G34W, G34R, and G34V mutant-specific antibodies for giant cell tumors of bone.
    Yamamoto H; Iwasaki T; Yamada Y; Matsumoto Y; Otsuka H; Yoshimoto M; Kohashi K; Taguchi K; Yokoyama R; Nakashima Y; Oda Y
    Hum Pathol; 2018 Mar; 73():41-50. PubMed ID: 29241742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blue lacy matrix in giant cell tumour of bone with or without denosumab therapy.
    Toda Y; Ishihara S; Kawai A; Yoshida A
    Virchows Arch; 2023 Jul; 483(1):125-129. PubMed ID: 36447097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of high-grade osteosarcoma in a patient with recurrent giant cell tumor of the ischium while receiving treatment with denosumab.
    Tsukamoto S; Righi A; Vanel D; Honoki K; Donati DM; Errani C
    Jpn J Clin Oncol; 2017 Nov; 47(11):1090-1096. PubMed ID: 29048579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Profiling of three H3F3A-mutated and denosumab-treated giant cell tumors of bone points to diverging pathways during progression and malignant transformation.
    Hasenfratz M; Mellert K; Marienfeld R; von Baer A; Schultheiss M; Roitman PD; Aponte-Tinao LA; Lehner B; Möller P; Mechtersheimer G; Barth TFE
    Sci Rep; 2021 Mar; 11(1):5709. PubMed ID: 33707617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malignant Transformation of a Giant Cell Tumor of Bone Treated with Denosumab: A Case Report.
    Park A; Cipriano CA; Hill K; Kyriakos M; McDonald DJ
    JBJS Case Connect; 2016; 6(3):e78. PubMed ID: 29252655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. H3F3A mutation in giant cell tumour of the bone is detected by immunohistochemistry using a monoclonal antibody against the G34W mutated site of the histone H3.3 variant.
    Lüke J; von Baer A; Schreiber J; Lübbehüsen C; Breining T; Mellert K; Marienfeld R; Schultheiss M; Möller P; Barth TFE
    Histopathology; 2017 Jul; 71(1):125-133. PubMed ID: 28211081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic Utility of Genetic and Immunohistochemical
    Wągrodzki M; Tysarowski A; Seliga K; Wojnowska A; Stepaniuk M; Castañeda Wysocka P; Makuła D; Pieńkowski A; Szostakowski B; Zub R; Rutkowski P
    Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35055156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Analysis of the molecular penotypes and histopathological features of giant cell tumor of bone with denosumab treatment].
    Gong LH; Dong RF; Zhang W; Sun XQ; Zhang M; Ding Y
    Zhonghua Bing Li Xue Za Zhi; 2021 Jan; 50(1):60-62. PubMed ID: 33396989
    [No Abstract]   [Full Text] [Related]  

  • 13. How safe and effective is denosumab for bone giant cell tumour?
    Errani C; Tsukamoto S; Mavrogenis AF
    Int Orthop; 2017 Nov; 41(11):2397-2400. PubMed ID: 28646421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Symplastic/pseudoanaplastic giant cell tumor of the bone.
    Sarungbam J; Agaram N; Hwang S; Lu C; Wang L; Healey J; Hameed M
    Skeletal Radiol; 2016 Jul; 45(7):929-35. PubMed ID: 27020452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absence of H3F3A mutation in a subset of malignant giant cell tumor of bone.
    Yoshida KI; Nakano Y; Honda-Kitahara M; Wakai S; Motoi T; Ogura K; Sano N; Shibata T; Okuma T; Iwata S; Kawai A; Ichimura K; Yoshida A
    Mod Pathol; 2019 Dec; 32(12):1751-1761. PubMed ID: 31285528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CORR Insights®: Is a Short-course of Preoperative Denosumab as Effective as Prolonged Therapy for Giant Cell Tumor of Bone?
    Ferguson PC
    Clin Orthop Relat Res; 2020 Nov; 478(11):2534-2536. PubMed ID: 32732739
    [No Abstract]   [Full Text] [Related]  

  • 17. Denosumab treatment of inoperable or locally advanced giant cell tumor of bone - Multicenter analysis outside clinical trial.
    Rutkowski P; Gaston L; Borkowska A; Stacchiotti S; Gelderblom H; Baldi GG; Palmerini E; Casali P; Gronchi A; Parry M; Campanacci DA; Scoccianti G; Wagrodzki M; Ferrari S; Dijkstra S; Pieńkowski A; Grimer R
    Eur J Surg Oncol; 2018 Sep; 44(9):1384-1390. PubMed ID: 29650420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malignant transformation of metastatic giant cell tumor of bone in a patient undergoing denosumab treatment: A case report.
    Yung D; Asano N; Hirozane T; Yamaguchi S; Mori T; Susa M; Okita H; Morioka H; Horiuchi K; Nakayama R
    J Orthop Sci; 2023 Nov; 28(6):1492-1496. PubMed ID: 34391616
    [No Abstract]   [Full Text] [Related]  

  • 19. Giant Cell Tumor of Bone With Pseudosarcomatous Changes Leading to Premature Denosumab Therapy Interruption: A Case Report With Review of the Literature.
    Sanchez-Pareja A; Larousserie F; Boudabbous S; Beaulieu JY; Mach N; Saiji E; Rougemont AL
    Int J Surg Pathol; 2016 Jun; 24(4):366-72. PubMed ID: 26842345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Denosumab, a Potential Alternative to the Surgical Treatment of Distal Radius Giant Cell Tumor of Bone: Case Report.
    Park MJ; Ganjoo KN; Ladd AL
    J Hand Surg Am; 2015 Aug; 40(8):1620-4. PubMed ID: 25935517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.